Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

By A. Sirén, M. Fratelli, M. Brines, C. Goemans, Simona Casagrande, P. Lewczuk, Sonja Keenan, C. Gleiter, C. Pasquali, A. Capobianco and 5 more. Proceedings of the National Academy of Sciences of the United States of America, 2001

1,062 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/27639821787047b807fc75717aee5a2687e9fc65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Kwon
2. H. Ehrenreich
3. W. Tetzlaff
4. M. Hasselblatt
5. J. Grauer
6. J. Beiner
7. C. Dembowski
8. A. Vaccaro

Citations in the corpus

• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial (2002, background): “Pathologic/regenerative processes of longer latency than examined in this study may also be beneficially affected (15,30).”
• Pathophysiology and pharmacologic treatment of acute spinal cord injury. (2004, background): “Erythropoeitan is thought to have anti-inflammatory, antioxidant and antiapoptotic properties [138–141] and in addition to demonstrating neuroprotection in the setting of experimental brain injury [142] has been shown to prevent motor neuron apoptosis and improve neurologic function in a global isch”